Partnering opportunity

Pioneering Belgian company for in vitro testing of skin care and dermatological products is offering services or collaboration to develop new therapeutics for inflammatory skin disorders

Summary

The Belgian SME is a research-based service provider making use of innovative skin models and methods to address efficacy & mechanisms of action of new products. In the context of chronic inflammatory skin diseases, the SME has developed specific models mimicking atopic dermatitis and psoriasis. These models are validated and respond positively to treatment with different benchmarks. The SME is looking for partners involved in new drug/product discovery and development for technical cooperation.

Partner sought

The company is looking for other companies or research groups who are developing cosmetic, pharmaceutic and skin care products and need to test their biological activity or study their mechanisms of action. The type of partnerships the company would consider is a technical cooperation agreements.

Description

The Belgian company is a research-based in vitro testing service provider making use of innovative skin models and methods to address efficacy and mechanisms of action of new products. The topics of research include inflammation and pigmentation disorders, wound healing, and ageing. Chronic inflammatory skin lesions are very common. While they occur in many different forms and exhibit a wide range of clinical conditions, they all involve a complex interplay between the skin barrier function, environmental factors, and immune responses. Current treatments are usually directed at decreasing cutaneous inflammation and alleviating pruritus, but they do not correct the underlying barrier defects that drive the process. Therefore, intense research has been performed to develop specific strategies to restore the epidermal integrity under inflammatory conditions. In this context, the company has developed specific in vitro models able to reproduce characteristic features of such chronic inflammatory disorders. These models are validated for screening and study of the mechanisms of action. They respond favorably to treatments with different benchmarks. (see below). With a strong commitment to extensive research and development, the company has been involved in many collaborative works requiring international cooperation such as European Framework programs (FP7) and Eurostars projects. In order to use and further develop its innovative models, the company is looking for other companies or research groups who are developing cosmetic, pharmaceutic and skin care products and need to test their biological activity or study their mechanisms of action. The type of partnerships the company would consider technical cooperation agreements.

Advantages and innovations

In the context of chronic inflammatory skin, while different in vitro models are able to reproduce characteristic features of specific disorders, few of them have been fully validated to respond favorably to treatments. The company has developed 3 models reproducing characteristic features of atopic dermatitis and psoriasis. These models are validated for screening and study of the mechanisms of action. They respond favorably to treatments with different benchmarks. In addition to these models and related functional assays, the company has also developed a bioinformatic tool with a unique skin-specific gene expression database that benefits from the state-of-the-art expertise in skin biology. This tool is very powerful to study the effects of new compounds at the whole transcriptome level and to better understand the mechanisms of action. Overall, the strengths of the company are: * Strong commitment in R&D * Validation of the models with benchmarks * Model publications in peer reviewed journals * Highly motivated and skilled scientists (6 PhD, 4 MSc) * Expertise and know-how dedicated to skin biology * Highly reactive, ease of dealing * Deep expertise in bioassay development, gene expression profiling and data interpretation * Deep expertise in organotypic 3D cultures, especially with reliable and standardized in vitro reconstituted skin and disease models. * Access to multiple platforms for biological and physicochemical assays including tissue culture, ELISA, microfluidic high throughput qPCR, GeneChip®. * Unique Skin-specific database that benefits from the state-of-the-art expertise in skin transcriptomics. * 15 years of experience in customized in vitro bioassays and transcriptomics data analysis with a unique data interpretation skillset in skin biology.

Development stage

Already on the market

Intellectual Property Rights (IPR)

Secret Know-how,Exclusive Rights


Register your interest

How it works

  • Tell us about yourself
  • We’ll discuss with you
  • We put the right partners in touch

EEN help you find the right partner, rather than you going it alone.

Our role is to review and collate the most suitable submissions, and then send them to the client who posted the opportunity. We consult with you, and the client, to make the process professional and easy.

These are live opportunities. Your registration of interest on the site is just like a professional approach to a business at a networking event. To stand the best chance of success, make your submission really sing. Sell why the client who posted the opportunity should work with you. Excite them. Ask questions. Try and avoid copy and pasting words from elsewhere.

Once the client has chosen their partner, we'll introduce them over email and keep in touch with both parties to see how it's going. Sometimes things progress quickly. Sometimes because of changing priorities for either party, things progress slowly, but you never know - your next big business break could start right here.

?What value does EEN add?
This is your pitch: remember to include your unique selling points (USP) and why someone would want to do business with you
Tell us why you are a good fit for this opportunity, and why you think you're the right people for this partnership
If there's anything additional, or commercially sensitive you'd like to know about this opportunity, please let us know

When you entered your email address above, we emailed you a code to verify you're human and have access to that account.

?What's this?

What next?

To finish up, we just need some extra details about you and your company